KLOW — GHK-Cu / TB-500 / BPC-157 / KPV Research Blend (80 mg)

Catalog ID: KLOW | Form: Lyophilized powder | Net Weight: 80 mg (50 mg + 10 mg + 10 mg + 10 mg)

Compound Overview

KLOW is a multi-component peptide blend formulated for laboratory exploration of cellular and tissue-regenerative pathways.
Each component is provided in research purity for controlled in vitro or in vivo studies where permitted by institutional guidelines.
Not for human use, diagnostic, or therapeutic application.

Composition (per 80 mg vial)

• GHK-Cu (50 mg) — Copper peptide complex studied for gene-expression modulation and cellular communication signaling.
• TB-500 (10 mg) — Thymosin β4 fragment investigated for cytoskeletal and actin-binding effects in model systems.
• BPC-157 (10 mg) — Synthetic peptide sequence examined for angiogenesis and tissue-modeling research.
• KPV (10 mg) — α-MSH tripeptide analog evaluated for epithelial barrier and immune-signaling studies.

Physical Characteristics

• Formulation: Lyophilized peptide blend (white to off-white powder)
• Purity: ≥ 98% (HPLC for each component)
• Solubility: Sterile bacteriostatic water or 0.6% acetic acid (research use only)
• Container: Sterile, sealed 3 mL glass vial

Storage & Stability

• Unreconstituted: Store at −20 °C in a dry environment.
• After reconstitution: Aliquot and store at −20 °C; avoid repeated freeze–thaw cycles.
• Protect from light and moisture.

Research Context

The combination of GHK-Cu, TB-500, BPC-157, and KPV is explored for potential in vitro synergy within cellular-signaling cascades, including
fibroblast migration, actin-polymerization dynamics, and epithelial integrity models.
KLOW is provided to facilitate controlled investigation into multi-peptide network interactions at the molecular level.